Pilot studies for development of an HIV subtype panel for surveillance of global diversity.


The continued global spread and evolution of HIV diversity pose significant challenges to diagnostics and vaccine strategies. NIAID partnered with the FDA, WRAIR, academia, and industry to form a Viral Panel Working Group to design and prepare a panel of well-characterized current and diverse HIV isolates. Plasma samples that had screened positive for HIV… (More)
DOI: 10.1089/AID.2011.0271


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.